they won’t run the funds down too low and 100 mil won’t go far on a phase3 trial and the other trials. Ok, they are not paying for the drug but 700 off patients is a lot to manage. Is Merck helping manage the trial?
they won’t run the funds down too low and 100 mil won’t go far...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.020(5.06%) |
Mkt cap ! $587.6M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 42.0¢ | 39.5¢ | $562.9K | 1.380M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 64103 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 196227 | 14 |
View Market Depth
| Last trade - 15.01pm 21/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |